Recent Developments in the Treatment of Pancreatic Cancer
Pancreatic duct adenocarcinoma is currently the sixth-leading cause of cancer death worldwide and the fourth in Europe, with a continuous increase in annual lethality in Portugal during the last two decades. Surgical en-bloc resection of the tumor with microscopic-negative margins and an adequate l...
Main Authors: | Jorge Paulino, Hélder Mansinho |
---|---|
Format: | Article |
Language: | English |
Published: |
Ordem dos Médicos
2023-10-01
|
Series: | Acta Médica Portuguesa |
Subjects: | |
Online Access: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19957 |
Similar Items
-
Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma
by: Shin Hye Hwang, et al.
Published: (2021-03-01) -
Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells reported in an asymptomatic patient: a rare case and literature review
by: Ramen Sakhi, et al.
Published: (2017-12-01) -
Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2020-08-01) -
Non-enhanced magnetic resonance imaging-based radiomics model for the differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma
by: Qi Li, et al.
Published: (2023-01-01) -
Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma
by: Maxime Barat, et al.
Published: (2021-06-01)